{"id":150527,"date":"2020-05-25T17:29:50","date_gmt":"2020-05-25T15:29:50","guid":{"rendered":"https:\/\/clinical.r-biopharm.com\/technologien\/qualitaetskontrollen\/"},"modified":"2026-08-20T13:02:59","modified_gmt":"2026-08-20T11:02:59","slug":"qualitaetskontrollen","status":"publish","type":"page","link":"https:\/\/clinical.r-biopharm.com\/de\/technologien\/qualitaetskontrollen\/","title":{"rendered":"Qualit\u00e4tskontrollen"},"content":{"rendered":"<div class=\"wpb-content-wrapper\">[mk_page_section padding_top=&#8220;30&#8243; padding_bottom=&#8220;30&#8243; sidebar=&#8220;sidebar-1&#8243;][vc_column width=&#8220;2\/3&#8243;][vc_row_inner][vc_column_inner][vc_column_text css=&#8220;.vc_custom_1705571484562{margin-bottom: 0px !important;}&#8220;]<strong>Optimierte Pr\u00e4zision der Testergebnisse mit Microbix Qualit\u00e4tskontrollen<\/strong><\/p>\n<p>Um die Exaktheit Ihrer diagnostischen Tests zu unterst\u00fctzen, empfehlen wir Ihnen die \u00a0hochwertigen Qualit\u00e4tskontrollen (Quality Assessment Products, QAPs\u2122) von Microbix Biosystems Inc.<\/p>\n<p>Das QAPs\u2122-Portfolio umfasst derzeit \u00fcber 100 Qualit\u00e4tskontrollen der Marken PROCEEDx\u2122, ONBOARD\u2122 und REDx\u2122. Diese Kontrollen dienen der \u00dcberwachung und Sicherstellung der Pr\u00e4zision von Tests zur Diagnose bakterieller und viraler Erkrankungen. Die Microbix Qulit\u00e4tskontrollen imitieren Patientenproben auf verl\u00e4ssliche Weise, sind jedoch dabei nicht infekti\u00f6s, stabil und f\u00fcr eine Vielzahl von Instrumenten geeignet.<\/p>\n<p>Die QAPs\u2122-Produkte decken Qualit\u00e4tskontrollen f\u00fcr sexuell \u00fcbertragbare Infektionen, respiratorische Infektionen, gastrointestinale Infektionen und f\u00fcr Hochrisikotypen von HPV ab.[\/vc_column_text][vc_empty_space height=&#8220;16px&#8220;][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner width=&#8220;1\/4&#8243;][vc_single_image image=&#8220;149293&#8243; img_size=&#8220;full&#8220;][\/vc_column_inner][vc_column_inner width=&#8220;3\/4&#8243;][vc_column_text css=&#8220;.vc_custom_1705571528778{margin-bottom: 0px !important;}&#8220;]<strong>Die Vorteile der Microbix Qualit\u00e4tskontrollen im \u00dcberblick:<\/strong><\/p>\n<ul>\n<li><strong>Authentische Nachbildung von Patientenproben:<\/strong> Hergestellt aus nativen Krankheitserregern, imitieren unsere Qualit\u00e4tskontrollen Patientenproben in klinisch relevanter Matrix.<\/li>\n<li><strong>Sicher und inaktiviert:<\/strong> Die Krankheitserreger sind inaktiviert und daher nicht infekti\u00f6s, gew\u00e4hrleisten jedoch weiterhin zuverl\u00e4ssige Testergebnisse.<\/li>\n<li><strong>Praktische Anwendung:<\/strong> Kontrollmaterial ist in gebrauchsfertigen Aliquots sowie als Swab verf\u00fcgbar.<\/li>\n<li><strong>Optimale Lagerung:<\/strong> Bei Temperaturen von 2 \u2013 8\u00b0C (Aliquots) bzw. 2 \u2013 30\u00b0C (Swabs) bleiben die Produkte bis zu zwei Jahre stabil.<\/li>\n<li><strong>Assay und Instrumente \u00fcbergreifend:<\/strong> Die Qualit\u00e4tskontrollen sind gegen f\u00fchrende Assays getestet und best\u00e4tigen somit ihre Zuverl\u00e4ssigkeit.<\/li>\n<li><strong>Breites Anwendungsspektrum:<\/strong> Geeignet f\u00fcr Immunoassays und Nukleins\u00e4uretests sowohl im Labor als auch im Point-of-Care Bereich<\/li>\n<li><strong>Negative Proben f\u00fcr pr\u00e4zise Testergebnisse:<\/strong> Speziell entwickelt, um die Anforderungen an molekulare Assays zu erf\u00fcllen, dienen negative Proben als zus\u00e4tzliche Testreferenz.<\/li>\n<\/ul>\n<p>Mit Microbix Qualit\u00e4tskontrollen erhalten Sie nicht nur eine zuverl\u00e4ssige Unterst\u00fctzung f\u00fcr Ihre diagnostischen Prozesse, sondern auch ein H\u00f6chstma\u00df an Pr\u00e4zision und Sicherheit. Vertrauen Sie auf unser Produktportfolio, um die Qualit\u00e4t Ihrer Tests zu gew\u00e4hrleisten und optimale Ergebnisse zu erzielen![\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_empty_space][vc_column_text css=&#8220;.vc_custom_1589801201282{margin-bottom: 0px !important;}&#8220;]\n<h3>Microbix QAPs\u2122 Produktlinien:<\/h3>\n[\/vc_column_text][vc_empty_space][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner width=&#8220;1\/4&#8243;][vc_empty_space][vc_single_image image=&#8220;150477&#8243; img_size=&#8220;full&#8220;][\/vc_column_inner][vc_column_inner width=&#8220;3\/4&#8243;][vc_column_text css=&#8220;.vc_custom_1592488465753{margin-bottom: 0px !important;}&#8220;]\n<h3>PROCEEDx\u2122<\/h3>\n<p>Qualit\u00e4tskontrollen zur Verifizierung und Validierung in internen Prozessen (RUO).[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_tta_tabs][vc_tta_section title=&#8220;Respiratorische Infektionen&#8220; tab_id=&#8220;1589800598209-5e4fa4f6-26bd&#8220;][vc_column_text css=&#8220;.vc_custom_1787211673326{margin-bottom: 0px !important;}&#8220;]Produktliste:<\/p>\n<ul>\n<li>PROCEEDx\u2122 Adenovirus Positive Sample (VP-15-01): <strong> <a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2024\/02\/sds_quality-assessment-products-qaps-formulated-with-non-hazardous-transport_medium_rev.0.pdf\" target=\"_blank\" rel=\"noopener\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122 Enterovirus Positive Sample VP-148-01: <strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_quality-assessment-products-qaps-formulated-with-non-hazardous-transport_medium_rev.0_13feb2026.pdf\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122 Human Metapneumovirus Positive Sample (VP-146-01): <strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_quality-assessment-products-qaps-formulated-with-non-hazardous-transport_medium_rev.0_13feb2026.pdf\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122 Influenza A Positive Sample (VP-13-01):<strong> <a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2024\/02\/sds_quality-assessment-products-qaps-formulated-with-non-hazardous-transport_medium_rev.0.pdf\" target=\"_blank\" rel=\"noopener\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122 Influenza A NAAT Positive Swab (VP-S-13-M1):\u00a0<strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_qap_dry_swab_rev.9_07nov2025.pdf\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122 Influenza B Positive Sample\u00a0(VP-14-01): <strong> <a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2024\/02\/sds_quality-assessment-products-qaps-formulated-with-non-hazardous-transport_medium_rev.0.pdf\" target=\"_blank\" rel=\"noopener\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122 Influenza B Positive Swab (VP-S-14-01): <strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_qap_dry_swab_rev.9_07nov2025.pdf\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122 Influenza B NAAT Positive Swab (VP-S-14-M1): <strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_qap_dry_swab_rev.9_07nov2025.pdf\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122 Influenza A + B Positive Sample (VP-13-02): <strong> <a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2024\/02\/sds_quality-assessment-products-qaps-formulated-with-non-hazardous-transport_medium_rev.0.pdf\" target=\"_blank\" rel=\"noopener\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122 Parainfluenza 3 Positive Sample (VP-10-M1):<strong> <a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2024\/02\/sds_quality-assessment-products-qaps-formulated-with-non-hazardous-transport_medium_rev.0.pdf\" target=\"_blank\" rel=\"noopener\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122 Respiratory Syncytial Virus (RSV) Positive Sample (VP-07-01):<strong> <a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2024\/02\/sds_quality-assessment-products-qaps-formulated-with-non-hazardous-transport_medium_rev.0.pdf\" target=\"_blank\" rel=\"noopener\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122 Rhinovirus Positive Sample (VP-147-01):\u00a0<strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_quality-assessment-products-qaps-formulated-with-non-hazardous-transport_medium_rev.0_13feb2026.pdf\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122 RSV Positive Swab (VP-S-07-01): <strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2024\/02\/sds_qap_dry_swab_rev.9_14122023.pdf\" target=\"_blank\" rel=\"noopener\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122 RSV NAAT Positive Swab (VP-S-07-M1):\u00a0<strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_qap_dry_swab_rev.9_07nov2025.pdf\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122 SARS-CoV-2 Positive Sample (VP-19-01):\u00a0<strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_qap_formulated_in_methanol_based_transport_medium_n_america_rev.8_14122023.pdf\">SDS<\/a><\/strong><\/li>\n<\/ul>\n[\/vc_column_text][\/vc_tta_section][vc_tta_section title=&#8220;Gastrointestinale Infektionen&#8220; tab_id=&#8220;1592488893311-f7682173-8bc6&#8243;][vc_column_text css=&#8220;.vc_custom_1787212359547{margin-bottom: 0px !important;}&#8220;]Produktliste:<\/p>\n<p><strong>Viren<\/strong><\/p>\n<ul>\n<li>PROCEEDx\u2122 Adeno F40\/41 (VP-128-01 ):\u00a0<strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_quality-assessment-products-qaps-formulated-with-non-hazardous-transport_medium_rev.0_13feb2026.pdf\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122 Astrovirus Positive Sample (VP-117-01):\u00a0<strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_quality-assessment-products-qaps-formulated-with-non-hazardous-transport_medium_rev.0_13feb2026.pdf\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122 Norovirus GI Positive Sample (VP-136-01): <strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_quality-assessment-products-qaps-formulated-with-non-hazardous-transport_medium_rev.0_13feb2026.pdf\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122 Norovirus GII Positive Sample (VP-118-01): <strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_quality-assessment-products-qaps-formulated-with-non-hazardous-transport_medium_rev.0_13feb2026.pdf\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122 Rotavirus Positive Sample MDx (VP-119-01): <strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_quality-assessment-products-qaps-formulated-with-non-hazardous-transport_medium_rev.0_13feb2026.pdf\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122 Rotavirus Positive Sample (VP-35-01): <strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_quality-assessment-products-qaps-formulated-with-non-hazardous-transport_medium_rev.0_13feb2026.pdf\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122 Sapovirus Positive Sample \u00a0(VP-116-01): <strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_quality-assessment-products-qaps-formulated-with-non-hazardous-transport_medium_rev.0_13feb2026.pdf\">SDS<\/a><\/strong><\/li>\n<\/ul>\n<p><strong>Bakterien<\/strong><\/p>\n<ul>\n<li>PROCEEDx\u2122 <em>Enterotoxigenic E. coli<\/em> Positive (VP-130-01): <strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_quality-assessment-products-qaps-formulated-with-non-hazardous-transport_medium_rev.0_13feb2026.pdf\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122 <em>Campylobacter jejuni<\/em> Positive Sample (VP-123-01): <strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_quality-assessment-products-qaps-formulated-with-non-hazardous-transport_medium_rev.0_13feb2026.pdf\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122 <em>Clostridium difficile<\/em> Positive (VP-125-01): <strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_quality-assessment-products-qaps-formulated-with-non-hazardous-transport_medium_rev.0_13feb2026.pdf\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122 <em>Clostridium difficile<\/em> Swab Positive (VP-S-125-01):\u00a0<strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_qap_dry_swab_rev.9_07nov2025.pdf\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122 <em>Clostridium difficile<\/em> GDH\/Toxin A\/Toxin B Positive Swab \u00a0(VP-S-39-02): <strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_qap_dry_swab_rev.9_07nov2025.pdf\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122FLOQ\u00ae <em>H. pylori<\/em> Positive Swab (VP-S-27-M1): <strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_qap_dry_swab_rev.9_07nov2025.pdf\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122FLOQ\u00ae <em>H. pylori<\/em> Positive Swab (VP-S-27-01):<strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_qap_dry_swab_rev.9_07nov2025.pdf\"> SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122 <em>Plesiomonas shigelloides<\/em> Positive (VP-131-01): <strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_quality-assessment-products-qaps-formulated-with-non-hazardous-transport_medium_rev.0_13feb2026.pdf\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122 <em>Salmonella enteritidis<\/em> Positive Sample (VP-126-01): <strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_quality-assessment-products-qaps-formulated-with-non-hazardous-transport_medium_rev.0_13feb2026.pdf\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122 Shiga Toxin producing<em> E. coli<\/em> Positive Sample (VP-127-01): <strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_quality-assessment-products-qaps-formulated-with-non-hazardous-transport_medium_rev.0_13feb2026.pdf\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122 <em>Shigella sonnei<\/em> Positive Sample (VP-121-01): <strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_quality-assessment-products-qaps-formulated-with-non-hazardous-transport_medium_rev.0_13feb2026.pdf\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122 <em>Vibrio parahaemolyticus<\/em> Positive (VP-122-01): <strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_quality-assessment-products-qaps-formulated-with-non-hazardous-transport_medium_rev.0_13feb2026.pdf\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122 <em>Yersinia enterocolitica<\/em> Positive Sample (VP-124-01): <strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_quality-assessment-products-qaps-formulated-with-non-hazardous-transport_medium_rev.0_13feb2026.pdf\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122 Negative Sample (VP-99-01): <strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_quality-assessment-products-qaps-formulated-with-non-hazardous-transport_medium_rev.0_13feb2026.pdf\">SDS<\/a><\/strong><\/li>\n<\/ul>\n<p><strong>Parasiten<\/strong><\/p>\n<ul>\n<li>PROCEEDx\u2122 <em>Cryptosporidium parvum<\/em> Positive Sample (VP-37-01): <strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_quality-assessment-products-qaps-formulated-with-non-hazardous-transport_medium_rev.0_13feb2026.pdf\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122 <em>Giardia lamblia<\/em> Positive Sample (VP-38-01): <strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_quality-assessment-products-qaps-formulated-with-non-hazardous-transport_medium_rev.0_13feb2026.pdf\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122 <em>Cryptosporidium parvum <\/em>and <em>Giardia lamblia <\/em>\u00a0Positive Sample (VP-37-02 ): <strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_quality-assessment-products-qaps-formulated-with-non-hazardous-transport_medium_rev.0_13feb2026.pdf\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122 <em>Entamoeba histolytica <\/em>Positive Sample (VP-138-01): <strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_quality-assessment-products-qaps-formulated-with-non-hazardous-transport_medium_rev.0_13feb2026.pdf\">SDS<\/a><\/strong><\/li>\n<\/ul>\n<p><strong>Multiplex<\/strong><\/p>\n<ul>\n<li>PROCEEDx\u2122 Enteric Viral Panel Positive Sample (Sapovirus, Astrovirus, Norovirus GI\/GII, Rotavirus, Adenovirus) (VP-115-M1): <strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_quality-assessment-products-qaps-formulated-with-non-hazardous-transport_medium_rev.0_13feb2026.pdf\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122 Enteric Viral Panel Swab Positive (VP-S-115-M1):\u00a0<a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_qap_dry_swab_rev.9_07nov2025.pdf\"><strong>SDS<\/strong><\/a><\/li>\n<li>PROCEEDx\u2122 Enteric Bacterial Panel 1 Positive (Product is formulated with inactivated <em>Shigella sonnei<\/em>, <em>Campylobacter jejuni<\/em>, <em>Salmonella enteritidis<\/em>, and STEC) (VP-120-M1):\u00a0<strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_quality-assessment-products-qaps-formulated-with-non-hazardous-transport_medium_rev.0_13feb2026.pdf\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122 Enteric Bacterial Panel 1 Swab Positive (VP-S-120-M1): <a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_qap_dry_swab_rev.9_07nov2025.pdf\"><strong>SDS<\/strong><\/a><\/li>\n<li>PROCEEDx\u2122 Enteric Bacterial Panel 2 Positive (Product is formulated with inactivated <em>Vibrio parahaemolyticus<\/em>,\u00a0 <em>Yersinia enterocolitica<\/em>, <em>Plesiomonas shigelloides<\/em>, and ETEC) (VP-129-M1): <strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_quality-assessment-products-qaps-formulated-with-non-hazardous-transport_medium_rev.0_13feb2026.pdf\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122 Enteric Bacterial Panel 2 Swab Positive (VP-S-129-M1): <a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_qap_dry_swab_rev.9_07nov2025.pdf\"><strong>SDS<\/strong><\/a><\/li>\n<li>PROCEEDx\u2122 Enteric Parasite Panel Positive Sample (Product is formulated with <em>Cryptosporidium parvum<\/em>, <em>Giardia lamblia<\/em>, <em>Entamoeba histolytica<\/em>) (VP-165-M1): <strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_quality-assessment-products-qaps-formulated-with-non-hazardous-transport_medium_rev.0_13feb2026.pdf\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122 Enteric Parasite Panel Swab Positive (VP-S-165-M1): <a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_qap_dry_swab_rev.9_07nov2025.pdf\"><strong>SDS<\/strong><\/a><\/li>\n<\/ul>\n[\/vc_column_text][\/vc_tta_section][vc_tta_section title=&#8220;Frauengesundheit&#8220; tab_id=&#8220;1592488577683-a0c30c82-8d66&#8243;][vc_column_text css=&#8220;.vc_custom_1787212448124{margin-bottom: 0px !important;}&#8220;]Produktliste:<\/p>\n<ul>\n<li>PROCEEDx\u2122 Bacterial Vaginosis Panel Positive Swab (Product is formulated with inactivated <em>Gardnerella vaginalis<\/em>,\u00a0 <em>Atopobium vaginae<\/em>, <em>Megasphaera <\/em>1, BVAB2, <em>Lactobacillus crispatus<\/em>, <em>Lactobacillus jensenii<\/em>, <em>Trichomonas vaginalis<\/em>, and human cells) (VP-S-105-M1):<strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_qap_dry_swab_rev.9_07nov2025.pdf\"> SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122 Candida Panel Positive Swab (Product is formulated with inactivated C<em>andida albicans, Candida glabrata, Candida krusei <\/em>and human cells) (VP-S-102-M2):\u00a0<strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_qap_dry_swab_rev.9_07nov2025.pdf\">SDS<\/a><\/strong><\/li>\n<\/ul>\n[\/vc_column_text][\/vc_tta_section][vc_tta_section title=&#8220;Sexuell \u00fcbertragbare Infektionen (STI)&#8220; tab_id=&#8220;1592488586760-05f47a8e-e932&#8243;][vc_column_text css=&#8220;.vc_custom_1787213086039{margin-bottom: 0px !important;}&#8220;]Produktliste:<\/p>\n<ul>\n<li>PROCEEDx\u2122 <em>Chlamydia trachomatis<\/em> + <em>Neisseria gonorrhoeae<\/em>\u00a0 Positive Sample (VP-12-M2):\u00a0<strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_qap_formulated_in_methanol_based_transport_medium_n_america_rev.8_14122023.pdf\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122 FLOQ<sup>\u00ae<\/sup> <em>Chlamydia trachomatis<\/em> + <em>Neisseria gonorrhoeae <\/em>Positive Swab (VP-S-12-M2):\u00a0<strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_qap_dry_swab_rev.9_07nov2025.pdf\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122FLOQ<sup>\u00ae<\/sup> <em>Haemophilus ducreyi<\/em> Positive Swab (VP-S-141-M1): <strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_qap_dry_swab_rev.9_07nov2025.pdf\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122 HSV 1 and HSV 2 Positive Sample (VP-02-M2):\u00a0<strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_quality-assessment-products-qaps-formulated-with-non-hazardous-transport_medium_rev.0_13feb2026.pdf\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122 FLOQ<sup>\u00ae<\/sup> HSV 1&amp;2\/VZV Positive Swab (VP-S-02-M5): <strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_qap_dry_swab_rev.9_07nov2025.pdf\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122 <em>Trichomonas vaginalis<\/em> Positive Sample (VP-61-01):\u00a0<strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_quality-assessment-products-qaps-formulated-with-non-hazardous-transport_medium_rev.0_13feb2026.pdf\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122FLOQ<sup>\u00ae<\/sup> <em>Trichomonas vaginalis<\/em> + <em>Mycoplasma genitalium <\/em>Positive Swab (VP-S-61-M2)<\/li>\n<li>PROCEEDx\u2122 STI Negative Control (VP-99-M1):\u00a0<strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_qap_formulated_in_methanol_based_transport_medium_n_america_rev.8_14122023.pdf\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122 NAAT Negative Swab (VP-S-99-M4): <strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_qap_dry_swab_rev.9_07nov2025.pdf\">SDS<\/a><\/strong><\/li>\n<\/ul>\n<p><strong>Multiplex:<\/strong><\/p>\n<ul>\n<li>PROCEEDx\u2122FLOQ<sup>\u00ae<\/sup> CT\/NG\/TV Positive Swab (VP-S-12-M4): <strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_qap_dry_swab_rev.9_07nov2025.pdf\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122FLOQ<sup>\u00ae<\/sup> CT\/NG\/TV\/MG Positive Swab (VP-S-12-M5): <strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_qap_dry_swab_rev.9_07nov2025.pdf\">SDS<\/a><\/strong><\/li>\n<li>PROCEEDx\u2122FLOQ<sup>\u00ae<\/sup> HSV 1&amp;2\/VZV\/<em>T. pallidum<\/em> Positive Swab (VP-S-03-M1): <strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_qap_dry_swab_rev.9_07nov2025.pdf\">SDS<\/a><\/strong><\/li>\n<\/ul>\n[\/vc_column_text][\/vc_tta_section][\/vc_tta_tabs][vc_empty_space][vc_row_inner][vc_column_inner width=&#8220;1\/4&#8243;][vc_single_image image=&#8220;150471&#8243; img_size=&#8220;full&#8220;][\/vc_column_inner][vc_column_inner width=&#8220;3\/4&#8243;][vc_column_text css=&#8220;.vc_custom_1592488046130{margin-bottom: 0px !important;}&#8220;]\n<h3>REDx\u2122 controls<\/h3>\n<p>Qualit\u00e4tskontrollen f\u00fcr die IVD-Qualit\u00e4tskontrolle.[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_tta_tabs][vc_tta_section title=&#8220;Frauengesundheit&#8220; tab_id=&#8220;1592487245493-b2f2a61d-2c58&#8243;][vc_column_text css=&#8220;.vc_custom_1786024176748{margin-bottom: 0px !important;}&#8220;]Produktliste:<\/p>\n<ul>\n<li>REDx\u2122 HPV 16\/18\/45 Positive Control (RED-62-M1): <strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2024\/02\/sds_redx-controls-formulated-with-methanol-transport-medium_rev.0_15jan2024.pdf\" target=\"_blank\" rel=\"noopener\">SDS<\/a><\/strong><\/li>\n<li>REDx\u2122 HPV 31\/33\/66 Positive Control (RED-62-M2): <strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2024\/02\/sds_redx-controls-formulated-with-methanol-transport-medium_rev.0_15jan2024.pdf\" target=\"_blank\" rel=\"noopener\">SDS<\/a><\/strong><\/li>\n<li>REDx\u2122 HPV 39\/51\/52Positive Control (RED-62-M3): <strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2024\/02\/sds_redx-controls-formulated-with-methanol-transport-medium_rev.0_15jan2024.pdf\" target=\"_blank\" rel=\"noopener\">SDS<\/a><\/strong><\/li>\n<\/ul>\n[\/vc_column_text][\/vc_tta_section][vc_tta_section title=&#8220;Respiratorische Infektionen&#8220; tab_id=&#8220;1592488067793-e26603b8-3bd3&#8243;][vc_column_text margin_bottom=&#8220;0&#8243; css=&#8220;.vc_custom_1787223770633{margin-bottom: 0px !important;}&#8220;]Produktliste:<\/p>\n<ul>\n<li>REDx\u2122 SARS-CoV-2 Positive Sample (RED-19-01): <strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2024\/02\/sds_redx-controls-formulated-with-methanol-transport-medium_rev.0_15jan2024.pdf\" target=\"_blank\" rel=\"noopener\">SDS<\/a><\/strong><\/li>\n<li>REDx\u2122 FLOQ\u00aeSARS-CoV-2 Positive Swab (RED-S-19-01):\u00a0<strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_redxfloq_dry-swab_rev-0_15jan2024_new.pdf\">SDS<\/a><\/strong><\/li>\n<li>REDx\u2122 FLOQ\u00aeSARS-CoV-2 Ag Positive Swab (RED-S-19-02): <strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_redxfloq_dry-swab_rev-0_15jan2024_new.pdf\">SDS<\/a><\/strong><\/li>\n<li>REDx\u2122 FLOQ\u00ae Respiratory Negative Swab (RED-S-99-01): <strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_redxfloq_dry-swab_rev-0_15jan2024_new.pdf\">SDS<\/a><\/strong><\/li>\n<li>REDx\u2122 SARS-CoV-2 Negative Swab (RED-S-99-M4): <strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_redxfloq_dry-swab_rev-0_15jan2024_new.pdf\">SDS<\/a><\/strong><\/li>\n<\/ul>\n<p><strong>Multiplex: <\/strong><\/p>\n<ul>\n<li>REDx\u2122FLOQ\u00ae SARS-CoV-2\/Flu A&amp;B\/RSV Swab Pos Ctrl (RED-S-19-M1): <strong><a href=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/sds_redxfloq_dry-swab_rev-0_15jan2024_new.pdf\">SDS<\/a><\/strong><\/li>\n<\/ul>\n[\/vc_column_text][\/vc_tta_section][\/vc_tta_tabs][vc_empty_space][vc_empty_space][vc_cta h2=&#8220;&#8220; shape=&#8220;square&#8220; style=&#8220;flat&#8220;]Microbix Produkte werden nur in den folgenden L\u00e4ndern vertrieben: Australien, Belgien, Frankreich, Deutschland, Luxemburg, Niederlande, Norwegen, Gro\u00dfbritannien, Kanada, Neuseeland, Spanien.[\/vc_cta][\/vc_column][vc_column width=&#8220;1\/3&#8243;][vc_cta h2=&#8220;Microbix QAPs\u2122&#8220; shape=&#8220;square&#8220; style=&#8220;flat&#8220; add_button=&#8220;bottom&#8220; btn_title=&#8220;Portfolio ansehen&#8220; btn_style=&#8220;flat&#8220; btn_shape=&#8220;square&#8220; btn_color=&#8220;inverse&#8220; css=&#8220;&#8220; btn_link=&#8220;url:https%3A%2F%2Fclinical.r-biopharm.com%2Fwp-content%2Fuploads%2Fmicrobix_quality_assesment_products_4p_de_2024-12.pdf|target:_blank&#8220;]Erfahren Sie mehr \u00fcber die Microbix Qualit\u00e4tskontrollen in unserer Brosch\u00fcre.[\/vc_cta][vc_cta h2=&#8220;HPV Qualit\u00e4tskontrollprodukte&#8220; shape=&#8220;square&#8220; style=&#8220;flat&#8220; add_button=&#8220;bottom&#8220; btn_title=&#8220;Portfolio ansehen&#8220; btn_style=&#8220;flat&#8220; btn_shape=&#8220;square&#8220; btn_color=&#8220;inverse&#8220; btn_link=&#8220;url:https%3A%2F%2Fclinical.r-biopharm.com%2Fwp-content%2Fuploads%2F2022%2F05%2Fmicrobix_hpv_flyer_2p_de_2022-02.pdf|target:_blank&#8220;]Erfahren Sie mehr \u00fcber die Microbix HPV Qualit\u00e4tskontrollen in unserer Brosch\u00fcre.[\/vc_cta][vc_cta h2=&#8220;COVID-19 Qualit\u00e4tskontrollprodukte&#8220; shape=&#8220;square&#8220; style=&#8220;flat&#8220; add_button=&#8220;bottom&#8220; btn_title=&#8220;Portfolio ansehen&#8220; btn_style=&#8220;flat&#8220; btn_shape=&#8220;square&#8220; btn_color=&#8220;inverse&#8220; btn_link=&#8220;url:https%3A%2F%2Fclinical.r-biopharm.com%2Fwp-content%2Fuploads%2F2022%2F05%2Fmicrobix_sars-cov-2_flyer_2p_de_2021-08.pdf|target:_blank&#8220;]Erfahren Sie mehr \u00fcber die Microbix COVID-19 Qualit\u00e4tskontrollen in unserer Brosch\u00fcre.[\/vc_cta][vc_row_inner disable_element=&#8220;yes&#8220;][vc_column_inner][vc_column_text margin_bottom=&#8220;20&#8243;]\n<h3 style=\"margin-bottom: 25px;\">Choose an indication<\/h3>\n<div class=\"facetwp-facet facetwp-facet-indication_fselect facetwp-type-fselect\" data-name=\"indication_fselect\" data-type=\"fselect\"><\/div>[\/vc_column_text][vc_column_text margin_bottom=&#8220;20&#8243;]\n<h3 style=\"margin-bottom: 25px;\">Choose a diagnostic field<\/h3>\n<div class=\"facetwp-facet facetwp-facet-diagnostics_fselect facetwp-type-fselect\" data-name=\"diagnostics_fselect\" data-type=\"fselect\"><\/div>[\/vc_column_text][vc_column_text margin_bottom=&#8220;40&#8243; css=&#8220;.vc_custom_1589800352907{margin-bottom: 40px !important;}&#8220;]\n<h3 style=\"margin-bottom: 25px;\">Choose your product<\/h3>\n<div class=\"facetwp-facet facetwp-facet-load_more_pager facetwp-type-pager\" data-name=\"load_more_pager\" data-type=\"pager\"><button class=\"facetwp-load-more\" data-loading=\"Loading...\">Load more<\/button><\/div>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/mk_page_section][mk_page_section bg_color=&#8220;#ffffff&#8220; padding_top=&#8220;0&#8243; sidebar=&#8220;sidebar-1&#8243;][vc_column css=&#8220;.vc_custom_1467042052405{margin-top: 40px !important;}&#8220;][vc_column_text margin_bottom=&#8220;20&#8243;]\n<h2 class=\"knubbel\">Das k\u00f6nnte Sie auch interessieren<\/h2>\n[\/vc_column_text][vc_row_inner css=&#8220;.vc_custom_1468404266697{margin-bottom: 40px !important;}&#8220;][vc_column_inner width=&#8220;1\/3&#8243; css=&#8220;.vc_custom_1468416557833{padding-bottom: 10px !important;padding-left: 0px !important;}&#8220;][mk_flipbox_rb taxonomy=&#8220;technology&#8220; tag_technology=&#8220;qpcr&#8220; min_height=&#8220;200&#8243; button_bg_color=&#8220;#4d4d4d&#8220; button_bg_hover_color=&#8220;#ffffff&#8220; button_text=&#8220;More&#8220;][\/vc_column_inner][vc_column_inner width=&#8220;1\/3&#8243; css=&#8220;.vc_custom_1468416552613{padding-right: 7.5px !important;padding-bottom: 10px !important;padding-left: 7.5px !important;}&#8220;][mk_flipbox_rb taxonomy=&#8220;technology&#8220; tag_technology=&#8220;qpcr&#8220; offset=&#8220;1&#8243; min_height=&#8220;200&#8243; button_bg_color=&#8220;#4d4d4d&#8220; button_bg_hover_color=&#8220;#ffffff&#8220; button_text=&#8220;More&#8220;][\/vc_column_inner][vc_column_inner width=&#8220;1\/3&#8243; css=&#8220;.vc_custom_1468416547451{padding-right: 0px !important;padding-bottom: 10px !important;}&#8220;][mk_flipbox_rb taxonomy=&#8220;technology&#8220; tag_technology=&#8220;qpcr&#8220; offset=&#8220;2&#8243; min_height=&#8220;200&#8243; button_bg_color=&#8220;#4d4d4d&#8220; button_bg_hover_color=&#8220;#ffffff&#8220; button_text=&#8220;More&#8220;][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/mk_page_section][mk_page_section bg_color=&#8220;#f7f7f7&#8243; padding_top=&#8220;20&#8243; padding_bottom=&#8220;20&#8243; sidebar=&#8220;sidebar-1&#8243;][vc_column css=&#8220;.vc_custom_1468415774645{padding-top: 0px !important;padding-bottom: 0px !important;}&#8220;][vc_column_text disable_pattern=&#8220;false&#8220; align=&#8220;center&#8220; css=&#8220;.vc_custom_1589795803907{margin-bottom: 0px !important;}&#8220;]\n<h2>Beratung zum Thema Qualit\u00e4tskontrolle<\/h2>\n<p>Fragen? Unser erfahrenes Team unterst\u00fctzt Sie gern mit individuell zugeschnittenen L\u00f6sungen f\u00fcr Ihre Diagnostik.[\/vc_column_text][mk_button dimension=&#8220;flat&#8220; url=&#8220;\/contact&#8220; align=&#8220;center&#8220; margin_bottom=&#8220;&#8220; bg_color=&#8220;#4d4d4d&#8220; btn_hover_bg=&#8220;#ffffff&#8220; btn_hover_txt_color=&#8220;#4d4d4d&#8220;]Kontakt[\/mk_button][\/vc_column][\/mk_page_section]\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[mk_page_section padding_top=&#8220;30&#8243; padding_bottom=&#8220;30&#8243; sidebar=&#8220;sidebar-1&#8243;][vc_column width=&#8220;2\/3&#8243;][vc_row_inner][vc_column_inner][vc_column_text css=&#8220;.vc_custom_1705571484562{margin-bottom: 0px !important;}&#8220;]Optimierte Pr\u00e4zision der Testergebnisse mit Microbix Qualit\u00e4tskontrollen Um die Exaktheit Ihrer diagnostischen Tests zu unterst\u00fctzen, empfehlen wir Ihnen die \u00a0hochwertigen Qualit\u00e4tskontrollen (Quality Assessment Products, QAPs\u2122) von Microbix Biosystems Inc. Das QAPs\u2122-Portfolio umfasst derzeit \u00fcber 100 Qualit\u00e4tskontrollen der Marken PROCEEDx\u2122, ONBOARD\u2122 und REDx\u2122. Diese Kontrollen dienen der \u00dcberwachung und [&hellip;]<\/p>\n","protected":false},"author":27,"featured_media":0,"parent":73580,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"content-type":"","_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"class_list":["post-150527","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Qualit\u00e4tskontrollen - Clinical Diagnostics<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/clinical.r-biopharm.com\/de\/technologien\/qualitaetskontrollen\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Qualit\u00e4tskontrollen - Clinical Diagnostics\" \/>\n<meta property=\"og:description\" content=\"[mk_page_section padding_top=&#8220;30&#8243; padding_bottom=&#8220;30&#8243; sidebar=&#8220;sidebar-1&#8243;][vc_column width=&#8220;2\/3&#8243;][vc_row_inner][vc_column_inner][vc_column_text css=&#8220;.vc_custom_1705571484562{margin-bottom: 0px !important;}&#8220;]Optimierte Pr\u00e4zision der Testergebnisse mit Microbix Qualit\u00e4tskontrollen Um die Exaktheit Ihrer diagnostischen Tests zu unterst\u00fctzen, empfehlen wir Ihnen die \u00a0hochwertigen Qualit\u00e4tskontrollen (Quality Assessment Products, QAPs\u2122) von Microbix Biosystems Inc. Das QAPs\u2122-Portfolio umfasst derzeit \u00fcber 100 Qualit\u00e4tskontrollen der Marken PROCEEDx\u2122, ONBOARD\u2122 und REDx\u2122. Diese Kontrollen dienen der \u00dcberwachung und [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/clinical.r-biopharm.com\/de\/technologien\/qualitaetskontrollen\/\" \/>\n<meta property=\"og:site_name\" content=\"Clinical Diagnostics\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-20T11:02:59+00:00\" \/>\n<meta name=\"twitter:label1\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data1\" content=\"8\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/clinical.r-biopharm.com\\\/de\\\/technologien\\\/qualitaetskontrollen\\\/\",\"url\":\"https:\\\/\\\/clinical.r-biopharm.com\\\/de\\\/technologien\\\/qualitaetskontrollen\\\/\",\"name\":\"Qualit\u00e4tskontrollen - Clinical Diagnostics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/clinical.r-biopharm.com\\\/fr\\\/#website\"},\"datePublished\":\"2020-05-25T15:29:50+00:00\",\"dateModified\":\"2026-08-20T11:02:59+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/clinical.r-biopharm.com\\\/de\\\/technologien\\\/qualitaetskontrollen\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/clinical.r-biopharm.com\\\/de\\\/technologien\\\/qualitaetskontrollen\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/clinical.r-biopharm.com\\\/de\\\/technologien\\\/qualitaetskontrollen\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/clinical.r-biopharm.com\\\/de\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Technologien\",\"item\":\"https:\\\/\\\/clinical.r-biopharm.com\\\/de\\\/technologien\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Qualit\u00e4tskontrollen\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/clinical.r-biopharm.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/clinical.r-biopharm.com\\\/fr\\\/\",\"name\":\"Clinical Diagnostics\",\"description\":\"A Division of the R-Biopharm Group\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/clinical.r-biopharm.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Qualit\u00e4tskontrollen - Clinical Diagnostics","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/clinical.r-biopharm.com\/de\/technologien\/qualitaetskontrollen\/","og_locale":"de_DE","og_type":"article","og_title":"Qualit\u00e4tskontrollen - Clinical Diagnostics","og_description":"[mk_page_section padding_top=&#8220;30&#8243; padding_bottom=&#8220;30&#8243; sidebar=&#8220;sidebar-1&#8243;][vc_column width=&#8220;2\/3&#8243;][vc_row_inner][vc_column_inner][vc_column_text css=&#8220;.vc_custom_1705571484562{margin-bottom: 0px !important;}&#8220;]Optimierte Pr\u00e4zision der Testergebnisse mit Microbix Qualit\u00e4tskontrollen Um die Exaktheit Ihrer diagnostischen Tests zu unterst\u00fctzen, empfehlen wir Ihnen die \u00a0hochwertigen Qualit\u00e4tskontrollen (Quality Assessment Products, QAPs\u2122) von Microbix Biosystems Inc. Das QAPs\u2122-Portfolio umfasst derzeit \u00fcber 100 Qualit\u00e4tskontrollen der Marken PROCEEDx\u2122, ONBOARD\u2122 und REDx\u2122. Diese Kontrollen dienen der \u00dcberwachung und [&hellip;]","og_url":"https:\/\/clinical.r-biopharm.com\/de\/technologien\/qualitaetskontrollen\/","og_site_name":"Clinical Diagnostics","article_modified_time":"2026-08-20T11:02:59+00:00","twitter_misc":{"Gesch\u00e4tzte Lesezeit":"8\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/clinical.r-biopharm.com\/de\/technologien\/qualitaetskontrollen\/","url":"https:\/\/clinical.r-biopharm.com\/de\/technologien\/qualitaetskontrollen\/","name":"Qualit\u00e4tskontrollen - Clinical Diagnostics","isPartOf":{"@id":"https:\/\/clinical.r-biopharm.com\/fr\/#website"},"datePublished":"2020-05-25T15:29:50+00:00","dateModified":"2026-08-20T11:02:59+00:00","breadcrumb":{"@id":"https:\/\/clinical.r-biopharm.com\/de\/technologien\/qualitaetskontrollen\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/clinical.r-biopharm.com\/de\/technologien\/qualitaetskontrollen\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/clinical.r-biopharm.com\/de\/technologien\/qualitaetskontrollen\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/clinical.r-biopharm.com\/de\/"},{"@type":"ListItem","position":2,"name":"Technologien","item":"https:\/\/clinical.r-biopharm.com\/de\/technologien\/"},{"@type":"ListItem","position":3,"name":"Qualit\u00e4tskontrollen"}]},{"@type":"WebSite","@id":"https:\/\/clinical.r-biopharm.com\/fr\/#website","url":"https:\/\/clinical.r-biopharm.com\/fr\/","name":"Clinical Diagnostics","description":"A Division of the R-Biopharm Group","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/clinical.r-biopharm.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"}]}},"_links":{"self":[{"href":"https:\/\/clinical.r-biopharm.com\/de\/wp-json\/wp\/v2\/pages\/150527","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clinical.r-biopharm.com\/de\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/clinical.r-biopharm.com\/de\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/clinical.r-biopharm.com\/de\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/clinical.r-biopharm.com\/de\/wp-json\/wp\/v2\/comments?post=150527"}],"version-history":[{"count":54,"href":"https:\/\/clinical.r-biopharm.com\/de\/wp-json\/wp\/v2\/pages\/150527\/revisions"}],"predecessor-version":[{"id":183070,"href":"https:\/\/clinical.r-biopharm.com\/de\/wp-json\/wp\/v2\/pages\/150527\/revisions\/183070"}],"up":[{"embeddable":true,"href":"https:\/\/clinical.r-biopharm.com\/de\/wp-json\/wp\/v2\/pages\/73580"}],"wp:attachment":[{"href":"https:\/\/clinical.r-biopharm.com\/de\/wp-json\/wp\/v2\/media?parent=150527"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}